Cargando…

Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension

Background: Community pharmacies in many countries around the world provide healthcare services for patients. Pharmacists trained as medication experts provide a wide range of patient care services related to medication therapy, patient education, disease prevention, and health promotion. Profession...

Descripción completa

Detalles Bibliográficos
Autores principales: Waszyk-Nowaczyk, Magdalena, Guzenda, Weronika, Plewka, Beata, Michalak, Michał, Cerbin-Koczorowska, Magdalena, Stryczyński, Łukasz, Byliniak, Michał, Ratka, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465715/
https://www.ncbi.nlm.nih.gov/pubmed/32784436
http://dx.doi.org/10.3390/jcm9082572
_version_ 1783577650337415168
author Waszyk-Nowaczyk, Magdalena
Guzenda, Weronika
Plewka, Beata
Michalak, Michał
Cerbin-Koczorowska, Magdalena
Stryczyński, Łukasz
Byliniak, Michał
Ratka, Anna
author_facet Waszyk-Nowaczyk, Magdalena
Guzenda, Weronika
Plewka, Beata
Michalak, Michał
Cerbin-Koczorowska, Magdalena
Stryczyński, Łukasz
Byliniak, Michał
Ratka, Anna
author_sort Waszyk-Nowaczyk, Magdalena
collection PubMed
description Background: Community pharmacies in many countries around the world provide healthcare services for patients. Pharmacists trained as medication experts provide a wide range of patient care services related to medication therapy, patient education, disease prevention, and health promotion. Professional training, expertise, and skills qualify pharmacists to engage in health screenings. These screening programs performed by community pharmacists can help to identify risk factors, facilitate early detection of common diseases, and assist physicians with making effective diagnoses. Objectives: In this study, we created and tested a novel model to provide professional monitoring and counseling on blood pressure by community pharmacists. The aims of the study were to identify the prevalence of elevated blood pressure among patients visiting a community pharmacy and describe the demographic characteristics of patients with hypertension (sex, age, education, body weight, and hypertension risk factors). Methods: The research project was conducted in an accredited community pharmacy in Poznan, Poland, from January to April 2019. A total of 118 anonymous patients (30.5% men and 69.5% women) participated in this study. To qualify for this study, participants had to be older than 18 years of age and have no previous diagnosis of hypertension or other cardiovascular disease. Results: Based on the blood pressure screenings, 61.9% of patients were qualified for the standard consultation (SC: normal blood pressure), 21.2% for the intensive consultation (IC: normal blood pressure and hypertension risk factor), 16.9% patients with elevated blood pressure for the high-risk consultation (HRC: referred to a physician), and 3.4% received a diagnosis of hypertension. We qualified 35.6% with a high-pressure value (greater than 140/90 mmHg). Conclusions: The novel model for blood pressure control screening and counseling implemented in a generally accessible community pharmacy may help with early detection of hypertension problems, lead to initiation of effective patient counseling by a community pharmacist, and result in early referral of the patient to a physician.
format Online
Article
Text
id pubmed-7465715
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74657152020-09-04 Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension Waszyk-Nowaczyk, Magdalena Guzenda, Weronika Plewka, Beata Michalak, Michał Cerbin-Koczorowska, Magdalena Stryczyński, Łukasz Byliniak, Michał Ratka, Anna J Clin Med Article Background: Community pharmacies in many countries around the world provide healthcare services for patients. Pharmacists trained as medication experts provide a wide range of patient care services related to medication therapy, patient education, disease prevention, and health promotion. Professional training, expertise, and skills qualify pharmacists to engage in health screenings. These screening programs performed by community pharmacists can help to identify risk factors, facilitate early detection of common diseases, and assist physicians with making effective diagnoses. Objectives: In this study, we created and tested a novel model to provide professional monitoring and counseling on blood pressure by community pharmacists. The aims of the study were to identify the prevalence of elevated blood pressure among patients visiting a community pharmacy and describe the demographic characteristics of patients with hypertension (sex, age, education, body weight, and hypertension risk factors). Methods: The research project was conducted in an accredited community pharmacy in Poznan, Poland, from January to April 2019. A total of 118 anonymous patients (30.5% men and 69.5% women) participated in this study. To qualify for this study, participants had to be older than 18 years of age and have no previous diagnosis of hypertension or other cardiovascular disease. Results: Based on the blood pressure screenings, 61.9% of patients were qualified for the standard consultation (SC: normal blood pressure), 21.2% for the intensive consultation (IC: normal blood pressure and hypertension risk factor), 16.9% patients with elevated blood pressure for the high-risk consultation (HRC: referred to a physician), and 3.4% received a diagnosis of hypertension. We qualified 35.6% with a high-pressure value (greater than 140/90 mmHg). Conclusions: The novel model for blood pressure control screening and counseling implemented in a generally accessible community pharmacy may help with early detection of hypertension problems, lead to initiation of effective patient counseling by a community pharmacist, and result in early referral of the patient to a physician. MDPI 2020-08-08 /pmc/articles/PMC7465715/ /pubmed/32784436 http://dx.doi.org/10.3390/jcm9082572 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Waszyk-Nowaczyk, Magdalena
Guzenda, Weronika
Plewka, Beata
Michalak, Michał
Cerbin-Koczorowska, Magdalena
Stryczyński, Łukasz
Byliniak, Michał
Ratka, Anna
Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension
title Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension
title_full Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension
title_fullStr Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension
title_full_unstemmed Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension
title_short Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension
title_sort screening services in a community pharmacy in poznan (poland) to increase early detection of hypertension
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465715/
https://www.ncbi.nlm.nih.gov/pubmed/32784436
http://dx.doi.org/10.3390/jcm9082572
work_keys_str_mv AT waszyknowaczykmagdalena screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension
AT guzendaweronika screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension
AT plewkabeata screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension
AT michalakmichał screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension
AT cerbinkoczorowskamagdalena screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension
AT stryczynskiłukasz screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension
AT byliniakmichał screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension
AT ratkaanna screeningservicesinacommunitypharmacyinpoznanpolandtoincreaseearlydetectionofhypertension